Journal profile · Computer Science-Computer Science Applications
Bioprinting
ISSN 2405-8866 · Elsevier
Bioprinting: subscription journal; APC about USD 3,940; review about 112 days (submission to acceptance, publisher); 76 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Bioprinting is published by Elsevier. By OpenAlex counts of its recent articles, its largest topics are 3D Printing in Biomedical Research, Hydrogels: synthesis, properties, applications and Tissue Engineering and Regenerative Medicine, together about 57.2% of its articles. Its main subfields are Biomedical Engineering. (generated from OpenAlex topic counts and CAS ranking data)
Bioprinting is a broad-spectrum, multidisciplinary journal that covers all aspects of 3D fabrication technology involving biological tissues, organs and cells for medical and biotechnology applications. Topics covered include nanomaterials, biomaterials, scaffolds, 3D printing technology, imaging and CAD/CAM software and hardware, post-printing bioreactor maturation, cell and biological factor patterning, biofabrication, tissue engineering and other applications of 3D bioprinting technology. Bioprinting publishes research reports describing novel results with high clinical significance in all areas of 3D bioprinting research. Bioprinting issues contain a wide variety of review and analysis articles covering topics relevant to 3D bioprinting ranging from basic biological, material and technical advances to pre-clinical and clinical applications of 3D bioprinting.Until 2022, Bioprinting published 4 volumes per year. Starting in 2023, the frequency was increased, and the journal now publishes 8 volumes per year.
From the journal's Aims & Scope
Research area (LetPub): Computer Science-Computer Science Applications
Editor-in-chief Anthony AtalaPublisher website
Editorial board by country: none in mainland China; most named United States 21, Australia 5, South Korea 4, United Kingdom 2, United Arab Emirates 2 (40 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- 3D Printing in Biomedical ResearchEngineering32.2%
- Hydrogels: synthesis, properties, applicationsBiochemistry, Genetics and Molecular Biology12.7%
- Tissue Engineering and Regenerative MedicineMedicine12.3%
- Additive Manufacturing and 3D Printing TechnologiesEngineering9.2%
- Cellular Mechanics and InteractionsBiochemistry, Genetics and Molecular Biology8.7%
- Bone Tissue Engineering MaterialsEngineering7.4%
- Microfluidic and Capillary Electrophoresis ApplicationsEngineering4.1%
- Anatomy and Medical TechnologyEngineering2.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Computer Science Applications | Q1 | 85/1022 | 91st |
| Biotechnology | Q1 | 32/325 | 90th |
| Biomedical Engineering | Q1 | 39/342 | 88th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 12.9LetPub ·
- CiteScore (publisher)
- 12.9Publisher website ·
- SJR 2026-06
- 1.1LetPub ·
- SNIP 2026-06
- 1.08LetPub ·
- h-index
- 62OpenAlex ·
- i10-index
- 310OpenAlex ·
- 2-year mean citedness
- 8.06OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 496 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 44 | 24 | 2,451 |
| 2025 | 76 | 33 | 3,202 |
| 2024 | 54 | 22 | 2,701 |
| 2023 | 64 | 27 | 2,033 |
| 2022 | 71 | 28 | 1,574 |
| 2021 | 65 | 28 | 1,087 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Publisher-reported review time from the journal's website
112 dayssubmission to acceptance
The publisher's own definition applies; dates from this journal's articles in the last 24 months are not available yet, so the publisher's figure is used.
Figures by source
- Submission to first decision
- 10 daysPublisher website ·
- First decision after review
- 50 daysPublisher website ·
- Submission to acceptance
- 112 daysPublisher website ·
- Acceptance to publication
- 2 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,940 / EUR 3,690 / GBP 3,150 / JPY 488,680 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare2 items from the author guidelines
- Abstract
- ≤ 250 words
- Keywords
- 1–7
Article types accepted3
- original researchOriginal Research: Provide a full length account of original research.Length not stated
- reviewReview: Provide an in-depth and up to date critical review of a related topic.Length not stated
- short communicationsShort Communications: Provide a short article of max 4 pages.Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Submission declaration: work not published previously (except preprint, abstract, lecture, thesis, registered report); not under consideration elsewhere; approved by all authors; not published elsewhere without consent. Model summary
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Data availability
Elsevier takes a neutral position on territorial disputes or jurisdictional claims; maps should only show the area actually studied; authors should use full standard title or standard abbreviation of institution. Model summary
Elsevier respects the decisions taken by its authors as to how they choose to designate territories and identify their affiliations in their published content.
Source ↗Publisher website ·- Publication ethics
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy. Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
Open access options available; referred to open access information page. Model summary
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process; initial editor assessment; typically reviewed by a minimum of two reviewers; editors make the decision. Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed; does not count as prior publication; free preprint posting service on SSRN offered. Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication. In support of Open Science, this journal offers its authors a free preprint posting service on SSRN, Elsevier’s preprint and early research …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- ISSN
- 2405-8866
- Official links
- Journal homepage ↗LetPub
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Bioprinting
How long does peer review take at Bioprinting?
The publisher reports about 112 days (submission to acceptance). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Bioprinting?
According to the journal's author guidelines: Abstract: ≤ 250 words; Keywords: 1–7. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Bioprinting based?
Of the 40 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (21), Australia (5) and South Korea (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Bioprinting?
According to LetPub and DOAJ records, Bioprinting is indexed in Scopus.
Is Bioprinting open access, and what is the APC?
Bioprinting is a subscription journal. APC about USD 3,940.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .